Arvaya Healthcare Ltd - 524723 - Corrigendum Of The Postal Ballot Notice Dated 13 July 2026.
Arvaya Healthcare issued a corrigendum to its Postal Ballot, rectifying a shareholding percentage and modifying the lock-in period for shareholders. This change impacts 14 non-promoter allottees of shares for the Sushodha Institute of Gastroenterology Private Limited (SIGPL) acquisition.
Jul 17 2026 22:34:00
Arvaya Healthcare Ltd - 524723 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Arvaya Healthcare is seeking shareholder approval for the acquisition of Sushodha Institute of Gastroenterology Private Limited for ₹15.48 crores. This acquisition will be funded through a preferential issue of 38.71 lakh equity shares at ₹40 each via a share swap, aiming to expand its specialized healthcare services.
Jul 13 2026 17:38:10
Arvaya Healthcare Ltd - 524723 - Announcement under Regulation 30 (LODR)-Acquisition
Arvaya Healthcare acquired 100% equity of Sushodha Institute of Gastroenterology Private Limited for Rs. 15.48 crore. The acquisition, funded through a share swap, expands the company's presence in specialized gastroenterology and healthcare services.
Jul 11 2026 14:56:14
Arvaya Healthcare Ltd - 524723 - Announcement under Regulation 30 (LODR)-Issue of Securities
Arvaya Healthcare's Board approved a rights issue to raise up to Rs. 210 crore. Additionally, a preferential issue of shares worth Rs. 15.49 crore was approved to acquire 100% equity of Sushodha Institute of Gastroenterology. This fundraise supports business synergies and market expansion.
Jul 11 2026 14:53:12
Arvaya Healthcare Ltd - 524723 - Announcement under Regulation 30 (LODR)-Raising of Funds
Bijoy Hans board approved a rights issue to raise up to Rs. 210 crores from eligible equity shareholders. Concurrently, a preferential issue worth Rs. 15.49 crores was approved to fund the 100% acquisition of Sushodha Institute of Gastroenterology Private Limited (SIGPL). Both are subject to shareholder and regulatory approvals.
Jul 11 2026 14:48:59
Arvaya Healthcare Ltd - 524723 - Board Meeting Outcome for Board Meeting Dated 11 July 2026
Arvaya Healthcare board approved the acquisition of 100% equity in Sushodha Institute of Gastroenterology Private Limited for ₹15.48 crores, funded by a preferential share issue. Additionally, the board approved raising up to ₹210 crores via a rights issue to support growth.
Jul 11 2026 14:43:44
Bijoy Hans Ltd - 524723 - Announcement under Regulation 30 (LODR)-Change of Company Name
Bijoy Hans Limited has changed its name to Arvaya Healthcare Limited. This name change, approved by BSE Limited, will be effective in the exchange's records from July 13, 2026, indicating a strategic reorientation of the company's business activities.
Jul 08 2026 16:04:26
Bijoy Hans Ltd - 524723 - Announcement under Regulation 30 (LODR)-Change in Directorate
Arvaya Healthcare's Board approved the appointment of Mr. Bidari Kotresh Anilkumar as an Additional Director, designated as Executive Director. He will serve a three-year term, effective from July 4, 2026, bringing over 12 years of leadership experience in healthcare operations.
Jul 04 2026 12:14:57
Bijoy Hans Ltd - 524723 - Board Meeting Outcome for Outcome Of Board Meeting Held On 4Th July, 2026
Arvaya Healthcare's Board appointed Mr. Bidari Kotresh Anilkumar as an Additional Director, designated as Executive Director, for a three-year term starting July 4, 2026. This appointment, based on the Nomination & Remuneration Committee's recommendation, is subject to shareholder approval.
Jul 04 2026 12:01:48
Read More